Keating Financial Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Buy
1,236
+180
+17% +$184K 0.2% 78
2026
Q1
$971K Sell
1,056
-10
-0.9% -$10.1K 0.16% 93
2025
Q4
$1.15M Buy
+1,066
New +$1.02M 0.16% 115

Other funds holding LLY

Keating Financial Advisory Services's LLY Position: Q2 2026 in Review

Keating Financial Advisory Services increased its Eli Lilly (LLY) stake by 17% in Q2 2026, buying an estimated $184K and bringing the position to 1,236 shares worth $1.48M. The position accounts for 0.2% of the portfolio, ranked #78.

Keating Financial Advisory Services first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Keating Financial Advisory Services held 1,236 shares of Eli Lilly worth $1.48M as of Q2 2026.
  • Keating Financial Advisory Services bought 180 Eli Lilly shares in Q2 2026, an estimated $184K.
  • Eli Lilly made up 0.2% of Keating Financial Advisory Services's portfolio in Q2 2026, its #78 holding.
  • Keating Financial Advisory Services first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.